Yan Q, Zhang X, Xie Y, Yang J, Liu C, Zhang M
Commun Biol. 2024; 7(1):181.
PMID: 38351296
PMC: 10864370.
DOI: 10.1038/s42003-024-05837-y.
Nabekura T, Deborah E, Tahara S, Arai Y, Love P, Kako K
Nat Commun. 2023; 14(1):7200.
PMID: 37938555
PMC: 10632368.
DOI: 10.1038/s41467-023-42578-8.
Haure-Mirande J, Audrain M, Ehrlich M, Gandy S
Mol Neurodegener. 2022; 17(1):55.
PMID: 36002854
PMC: 9404585.
DOI: 10.1186/s13024-022-00552-w.
Brauning A, Rae M, Zhu G, Fulton E, Admasu T, Stolzing A
Cells. 2022; 11(6).
PMID: 35326467
PMC: 8947539.
DOI: 10.3390/cells11061017.
Li G, Forster-Benson E, Sanders C
Biochim Biophys Acta Biomembr. 2019; 1862(1):183058.
PMID: 31494120
PMC: 6899207.
DOI: 10.1016/j.bbamem.2019.183058.
Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.
Jensen I, Winborn C, Fosdick M, Shao P, Tremblay M, Shan Q
PLoS Pathog. 2018; 14(10):e1007405.
PMID: 30379932
PMC: 6231673.
DOI: 10.1371/journal.ppat.1007405.
Natural Killer Cells: Development, Maturation, and Clinical Utilization.
Abel A, Yang C, Thakar M, Malarkannan S
Front Immunol. 2018; 9:1869.
PMID: 30150991
PMC: 6099181.
DOI: 10.3389/fimmu.2018.01869.
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy.
Paul S, Lal G
Front Immunol. 2017; 8:1124.
PMID: 28955340
PMC: 5601256.
DOI: 10.3389/fimmu.2017.01124.
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
Liu D, Tian S, Zhang K, Xiong W, Lubaki N, Chen Z
Protein Cell. 2017; 8(12):861-877.
PMID: 28488245
PMC: 5712291.
DOI: 10.1007/s13238-017-0415-5.
Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice.
Gaynor L, Colucci F
Front Immunol. 2017; 8:467.
PMID: 28484462
PMC: 5402472.
DOI: 10.3389/fimmu.2017.00467.
Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.
Miner C, K Giri T, Meyer C, Shabsovich M, Tripathy S
J Immunol. 2015; 194(4):1945-53.
PMID: 25582853
PMC: 4410706.
DOI: 10.4049/jimmunol.1402408.
Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation.
Nabekura T, Lanier L
J Exp Med. 2014; 211(12):2455-65.
PMID: 25366966
PMC: 4235640.
DOI: 10.1084/jem.20140798.
The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands.
Ma B, Craveiro Salvado C, Kane K
Immunogenetics. 2014; 66(7-8):467-77.
PMID: 24797174
DOI: 10.1007/s00251-014-0777-2.
Ly49 receptors: innate and adaptive immune paradigms.
Rahim M, Tu M, Mahmoud A, Wight A, Abou-Samra E, Lima P
Front Immunol. 2014; 5:145.
PMID: 24765094
PMC: 3980100.
DOI: 10.3389/fimmu.2014.00145.
Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection.
Nabekura T, Kanaya M, Shibuya A, Fu G, Gascoigne N, Lanier L
Immunity. 2014; 40(2):225-34.
PMID: 24440149
PMC: 3943894.
DOI: 10.1016/j.immuni.2013.12.011.
Targeting of a natural killer cell receptor family by a viral immunoevasin.
Berry R, Ng N, Saunders P, Vivian J, Lin J, Deuss F
Nat Immunol. 2013; 14(7):699-705.
PMID: 23666294
DOI: 10.1038/ni.2605.
The bone marrow functions as the central site of proliferation for long-lived NK cells.
van Helden M, de Graaf N, Boog C, Topham D, Zaiss D, Sijts A
J Immunol. 2012; 189(5):2333-7.
PMID: 22821961
PMC: 3427014.
DOI: 10.4049/jimmunol.1200008.
The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.
Alvarez-Breckenridge C, Yu J, Price R, Wei M, Wang Y, Nowicki M
J Virol. 2012; 86(8):4566-77.
PMID: 22318143
PMC: 3318659.
DOI: 10.1128/JVI.05545-11.
Cloning and characterization of CD300d, a novel member of the human CD300 family of immune receptors.
Comas-Casellas E, Martinez-Barriocanal A, Miro F, Ejarque-Ortiz A, Schwartz Jr S, Martin M
J Biol Chem. 2012; 287(13):9682-9693.
PMID: 22291008
PMC: 3322970.
DOI: 10.1074/jbc.M111.279224.
Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis.
Palazzo S, Simpson T, Schnapp L
Dimens Crit Care Nurs. 2011; 31(1):1-6.
PMID: 22156803
PMC: 4754668.
DOI: 10.1097/DCC.0b013e31823a5298.